Foundation: Bodor Laboratories, Inc. was established to further develop the portfolio of therapeutics designed to have significantly enhanced safety through utilizing the Retrometabolic Drug Design & Delivery (RMDD) concepts invented by Prof. Dr. Nicholas S. Bodor
This concept has resulted in numerous patents that have led to novel drugs in development and on the market that have demonstrated efficacy and dramatically superior safety
Our portfolio of intellectual property provides opportunities to develop therapies in dermatology, ophthalmology, respiratory, and other applications to treat a variety of disease states.
Bodor Laboratories, Inc. has established strong collaborations through out-licensing our technologies for various uses. Both with our partners and through our independent development, we have extensive pre-clinical and clinical data, as well as active Investigational New Drug (IND) applications. We are interested in forming new partnerships to develop other aspects of our strong and varied portfolio of intellectual property.